Profile data is unavailable for this security.
About the company
Owens & Minor, Inc. is a healthcare solutions company with integrated technologies, products and services. The Company operates through two segments: Global Solutions and Global Products. Global Solutions segment includes its United States distribution, outsourced logistics and value-added services business. Global Products manufactures and sources medical surgical products through its production and kitting operations. Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes products purchased from manufacturers and its own proprietary products. Global Products segment provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its manufacturing facilities are located in the United States, Thailand, Honduras, Mexico and Ireland.
- Revenue in USD (TTM)7.98bn
- Net income in USD32.90m
- Incorporated1993
- Employees6.40k
- LocationOwens & Minor Inc9120 LOCKWOOD BLVDMECHANICSVILLE 23116United StatesUSA
- Phone+1 (804) 723-7000
- Fax+1 (804) 723-7100
- Websitehttp://www.owens-minor.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GenMark Diagnostics, Inc | 148.67m | -25.21m | 1.00bn | 437.00 | -- | 10.58 | -- | 6.73 | -0.4059 | -0.4059 | 2.31 | 1.32 | 0.9923 | 5.66 | 11.15 | 340,205.90 | -16.82 | -53.95 | -21.24 | -69.24 | 38.79 | 40.59 | -16.96 | -84.17 | 3.84 | -2.38 | 0.4295 | -- | 24.40 | 23.54 | 6.24 | -- | -19.20 | -- |
| Fulgent Genetics Inc | 135.12m | 47.71m | 1.05bn | 139.00 | 21.49 | 5.41 | 19.70 | 7.80 | 2.02 | 2.02 | 6.16 | 8.02 | 0.8761 | -- | 2.77 | 972,093.50 | 33.13 | -7.55 | 41.47 | -7.98 | 69.16 | 55.06 | 37.82 | -16.57 | -- | -- | 0.00 | -- | 52.35 | 91.05 | 92.67 | -- | 10.09 | -- |
| Atrion Corporation | 149.81m | 32.79m | 1.07bn | 616.00 | 32.99 | 4.49 | 24.21 | 7.14 | 17.73 | 17.74 | 81.03 | 130.19 | 0.5764 | 1.89 | 8.21 | 243,202.90 | 12.62 | 16.10 | 13.23 | 16.93 | 45.21 | 47.33 | 21.89 | 21.61 | 5.08 | -- | 0.00 | 26.06 | 1.72 | 1.95 | 7.27 | 5.73 | 10.04 | 15.84 |
| BioLife Solutions Inc | 41.66m | -7.44m | 1.08bn | 151.00 | -- | 5.67 | -- | 25.93 | -0.2706 | -0.2706 | 1.73 | 5.82 | 0.2974 | 2.03 | 8.00 | 275,874.20 | -5.31 | -31.90 | -5.58 | -35.43 | 59.28 | 65.20 | -17.87 | -57.98 | 13.96 | -- | 0.00 | -- | 38.64 | 34.62 | 93.46 | -- | 31.63 | -- |
| Heska Corp | 166.77m | -18.59m | 1.20bn | 386.00 | -- | 4.37 | -- | 7.21 | -2.23 | -2.23 | 20.30 | 29.07 | 0.5487 | 2.94 | 7.74 | 432,044.00 | -6.13 | 5.38 | -6.67 | 6.70 | 42.30 | 43.55 | -11.18 | 6.16 | 3.79 | -0.0831 | 0.1599 | -- | -3.75 | 6.43 | -125.04 | -- | -14.88 | -- |
| Eargo, Inc. | -100.00bn | -100.00bn | 1.33bn | 184.00 | -- | -- | -- | -- | -- | -- | -- | -0.2403 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.363 | -- | 5.44 | -- | 41.56 | -- | -30.94 | -- | -- | -- |
| Cardiovascular Systems Inc | 232.60m | -23.53m | 1.42bn | 779.00 | -- | 5.28 | -- | 6.09 | -0.6712 | -0.6712 | 6.56 | 6.69 | 0.8325 | 2.00 | 7.20 | 298,586.70 | -8.42 | -8.25 | -10.10 | -10.19 | 79.08 | 80.57 | -10.12 | -7.71 | 5.61 | -23.48 | 0.0718 | -- | -4.63 | 5.44 | -10,580.78 | -- | -28.11 | -- |
| Inmode Ltd | 177.92m | 57.95m | 1.52bn | 251.00 | 31.02 | 6.56 | 26.11 | 8.56 | 1.38 | 1.38 | 4.24 | 6.52 | 0.7671 | 2.25 | 14.96 | 708,852.60 | 24.97 | -- | 28.77 | -- | 85.21 | -- | 32.56 | -- | 6.80 | -- | 0.00 | -- | 56.11 | -- | 173.32 | -- | -- | -- |
| Pulmonx Corp | 33.25m | -27.60m | 1.67bn | 202.00 | -- | -- | -- | 50.11 | -0.8332 | -0.8332 | 1.01 | 0.0199 | -- | -- | -- | 184,722.20 | -- | -- | -- | -- | 64.54 | -- | -83.02 | -- | 3.05 | -7.69 | 0.9851 | -- | 62.94 | -- | -12.04 | -- | -- | -- |
| Nano-X Imaging Ltd | -100.00bn | -100.00bn | 1.70bn | 27.00 | -- | 7.02 | -- | -- | -- | -- | -- | 5.25 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1,081.93 | -- | -- | -- |
| Owens & Minor, Inc. | 7.98bn | 32.90m | 1.70bn | 6.40k | 43.01 | 3.27 | 13.02 | 0.2133 | 0.5387 | -0.9824 | 131.21 | 7.08 | 2.29 | 6.28 | 11.16 | 1,247,605.00 | 0.9419 | -1.05 | 1.54 | -1.71 | 11.54 | 12.17 | 0.412 | -0.3517 | 0.7008 | 1.86 | 0.709 | -- | -2.20 | -0.4905 | 94.28 | -- | -5.91 | -60.19 |
| Axonics Modulation Technologies Inc | 86.70m | -66.32m | 1.80bn | 302.00 | -- | 6.13 | -- | 20.82 | -1.96 | -1.96 | 2.49 | 7.39 | 0.366 | 1.27 | 9.32 | 287,079.50 | -28.00 | -- | -31.63 | -- | 58.10 | -- | -76.49 | -- | 7.48 | -- | 0.0665 | -- | 1,854.74 | -- | -146.08 | -- | -- | -- |
| AtriCure Inc. | 210.13m | -45.69m | 1.84bn | 730.00 | -- | 4.40 | -- | 8.74 | -1.16 | -1.16 | 5.17 | 9.27 | 0.3313 | 1.88 | 8.04 | 287,845.20 | -7.20 | -9.38 | -7.75 | -10.56 | 72.17 | 72.60 | -21.74 | -16.12 | 5.85 | -11.69 | 0.1292 | -- | 14.47 | 16.52 | -57.86 | -- | 17.20 | -- |
| Avanos Medical Inc | 719.60m | 13.90m | 2.00bn | 4.70k | 145.54 | 1.55 | 34.92 | 2.78 | 0.2874 | 0.2874 | 15.03 | 26.97 | 0.399 | 1.98 | 4.23 | 153,106.40 | 0.7708 | -2.78 | 0.8662 | -3.28 | 54.77 | 55.49 | 1.93 | -9.38 | 2.14 | 1.46 | 0.1615 | -- | 6.94 | -16.04 | -270.16 | -- | -8.41 | -- |
| Cantel Medical Corp. | 1.02bn | 2.84m | 2.33bn | 3.67k | 817.19 | 3.20 | 34.88 | 2.30 | 0.0677 | 0.3254 | 24.04 | 17.30 | 0.6467 | 3.62 | 6.88 | 276,927.80 | 0.181 | 5.64 | 0.2023 | 6.46 | 45.53 | 46.85 | 0.2799 | 6.44 | 2.67 | 2.47 | 0.5931 | 11.31 | 10.66 | 12.45 | -94.98 | -43.06 | 21.51 | 16.63 |
| Integer Holdings Corp | 1.13bn | 72.88m | 2.36bn | 8.25k | 32.64 | 1.92 | 15.51 | 2.09 | 2.20 | 2.20 | 34.14 | 37.51 | 0.4701 | 4.74 | 5.41 | 136,984.30 | 3.03 | 1.69 | 3.26 | 1.83 | 25.53 | 29.98 | 6.45 | 3.91 | 2.23 | 2.43 | 0.4050 | 0.00 | 3.55 | 12.84 | 57.18 | 10.46 | 14.19 | -- |
Data as of Nov 23 2020. Currency figures normalised to Owens & Minor Inc's reporting currency: US Dollar USD
40.60%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2020 | 9.00m | 12.24% |
| The Vanguard Group, Inc.as of 30 Sep 2020 | 4.76m | 6.47% |
| Dimensional Fund Advisors LPas of 30 Sep 2020 | 4.36m | 5.93% |
| Renaissance Technologies LLCas of 30 Sep 2020 | 3.06m | 4.16% |
| SSgA Funds Management, Inc.as of 30 Sep 2020 | 2.47m | 3.37% |
| JPMorgan Investment Management, Inc.as of 30 Sep 2020 | 1.66m | 2.25% |
| Deerfield Management Company LPas of 30 Sep 2020 | 1.48m | 2.01% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2020 | 1.10m | 1.50% |
| Geode Capital Management LLCas of 30 Sep 2020 | 1.01m | 1.38% |
| Invesco Capital Management LLCas of 30 Sep 2020 | 956.02k | 1.30% |
More ▼
Data from 30 Sep 2020 - 30 Sep 2020Source: FactSet Research Systems Inc.
